Animal models of nonalcoholic fatty liver disease (original) (raw)

• Cheung, O. & Sanyal, A. J. Recent advances in nonalcoholic fatty liver disease. Curr. Opin. Gastroenterol. 26, 202–208 (2010).
  PubMed Google Scholar
• Ludwig, J., Viggiano, T. R., McGill, D. B. & Oh, B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 55, 434–438 (1980).
  CAS PubMed Google Scholar
• Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N. Engl. J. Med. 348, 1625–1638 (2003).
  PubMed Google Scholar
• Veldt, B. J. et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47, 1856–1862 (2008).
  PubMed Google Scholar
• Chen, C. L. et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135, 111–121 (2008).
  CAS PubMed Google Scholar
• Wieckowska, A. & Feldstein, A. E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin. Liver Dis. 28, 386–395 (2008).
  CAS PubMed Google Scholar
• Tiniakos, D. G., Vos, M. B. & Brunt, E. M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu. Rev. Pathol. 5, 145–171 (2010).
  CAS PubMed Google Scholar
• Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A. & Bacon, B. R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467–2474 (1999).
  CAS PubMed Google Scholar
• Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005).
  PubMed Google Scholar
• [No authors listed] Alcoholic liver disease: morphological manifestation. Review by an international group. Lancet 317, 707–711 (1981).
• Lefkowitch, J. H. Morphology of alcoholic liver disease. Clin. Liver Dis. 9, 37–53 (2005).
  PubMed Google Scholar
• Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413–1419 (1999).
  CAS PubMed Google Scholar
• Stumptner, C., Fuchsbichler, A., Heid, H., Zatloukal, K. & Denk, H. Mallory body—a disease-associated type of sequestosome. Hepatology 35, 1053–1062 (2002).
  CAS PubMed Google Scholar
• Brunt, E. M. Histopathology of non-alcoholic fatty liver disease. Clin. Liver Dis. 13, 533–544 (2009).
  PubMed Google Scholar
• Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372–384 (2010).
  PubMed Google Scholar
• Day, C. P. & Saksena, S. Non-alcoholic steatohepatitis: definitions and pathogenesis. J. Gastroenterol. Hepatol 17 (Suppl. 3), S377–S384 (2002).
  PubMed Google Scholar
• Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. & Tiribelli, C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 14, 72–81 (2008).
  CAS PubMed Google Scholar
• Pan, M. et al. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113, 1277–1287 (2004).
  CAS PubMed PubMed Central Google Scholar
• Feldstein, A. E. et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway. Hepatology 40, 185–194 (2004).
  CAS PubMed Google Scholar
• Wueest, S. et al. Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. J. Clin. Invest. 120, 191–202 (2010).
  CAS PubMed Google Scholar
• Anstee, Q. M. & Goldin, R. D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87, 1–16 (2006).
  CAS PubMed PubMed Central Google Scholar
• Rinella, M. E. & Green, R. M. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J. Hepatol. 40, 47–51 (2004).
  CAS PubMed Google Scholar
• Rinella, M. E. et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res. 49, 1068–1076 (2008).
  CAS PubMed PubMed Central Google Scholar
• Weltman, M. D., Farrell, G. C. & Liddle, C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111, 1645–1653 (1996).
  CAS PubMed Google Scholar
• Leclercq, I. A. et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest. 105, 1067–1075 (2000).
  CAS PubMed PubMed Central Google Scholar
• Ip, E. et al. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38, 123–132 (2003).
  CAS PubMed Google Scholar
• George, J. et al. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J. Hepatol. 39, 756–764 (2003).
  CAS PubMed Google Scholar
• Phung, N. et al. Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis. Int. J. Mol. Med. 24, 171–180 (2009).
  CAS PubMed Google Scholar
• Ip, E., Farrell, G., Hall, P., Robertson, G. & Leclercq, I. Administration of the potent PPARalpha agonist, Wy-14643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39, 1286–1296 (2004).
  CAS PubMed Google Scholar
• Leclercq, I. A., Farrell, G. C., Sempoux, C., dela Pena, A. & Horsmans, Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J. Hepatol. 41, 926–934 (2004).
  CAS PubMed Google Scholar
• Dela Pena, A. et al. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129, 1663–1674 (2005).
  CAS PubMed Google Scholar
• Yu, J. et al. COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator. Hepatology 43, 826–836 (2006).
  CAS PubMed Google Scholar
• McCuskey, R. S. et al. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 40, 386–393 (2004).
  PubMed Google Scholar
• Larter, C. Z., Yeh, M. M., Williams, J., Bell-Anderson, K. S. & Farrell, G. C. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. J. Hepatol. 49, 407–416 (2008).
  CAS PubMed Google Scholar
• Leclercq, I. A., Lebrun, V. A., Starkel, P. & Horsmans, Y. J. Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARgamma agonist pioglitazone. Lab. Invest. 87, 56–65 (2007).
  CAS PubMed Google Scholar
• Nagasawa, T. et al. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. Eur. J. Pharmacol. 536, 182–191 (2006).
  CAS PubMed Google Scholar
• Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M. & Czaja, M. J. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J. Biol. Chem. 280, 9887–9894 (2005).
  CAS PubMed Google Scholar
• Schattenberg, J. M. et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43, 163–172 (2006).
  CAS PubMed Google Scholar
• Nakae, D. Endogenous liver carcinogenesis in the rat. Pathol. Int. 49, 1028–1042 (1999).
  CAS PubMed Google Scholar
• Nakae, D. et al. Comparative changes in the liver of female Fischer-344 rats after short-term feeding of a semipurified or a semisynthetic L-amino acid-defined choline-deficient diet. Toxicol. Pathol. 23, 583–590 (1995).
  CAS PubMed Google Scholar
• Kodama, Y. et al. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 137, 1467–1477 (2009).
  CAS PubMed Google Scholar
• Lieber, C. S. et al. Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 79, 502–509 (2004).
  CAS PubMed Google Scholar
• Deng, Q. G. et al. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42, 905–914 (2005).
  CAS PubMed Google Scholar
• Zou, Y. et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 79, 1100–1107 (2006).
  CAS PubMed Google Scholar
• Baumgardner, J. N., Shankar, K., Hennings, L., Badger, T. M. & Ronis, M. J. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G27–G38 (2008).
  CAS PubMed Google Scholar
• Gami, A. S. et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49, 403–414 (2007).
  CAS PubMed Google Scholar
• Kim, J. K. et al. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J. Clin. Invest. 105, 1791–1797 (2000).
  CAS PubMed PubMed Central Google Scholar
• Jornayvaz, F. R., Samuel, V. T. & Shulman, G. I. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu. Rev. Nutr. 30, 273–290 (2010).
  CAS PubMed PubMed Central Google Scholar
• Jeong, W.-I. et al. Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J. Vet. Med. Sci. 67, 235–242 (2005).
  CAS PubMed Google Scholar
• Paigen, B., Morrow, A., Brandon, C., Mitchell, D. & Holmes, P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65–73 (1985).
  CAS PubMed Google Scholar
• Vergnes, L., Phan, J., Strauss, M., Tafuri, S. & Reue, K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 278, 42774–42784 (2003).
  CAS PubMed Google Scholar
• Wouters, K. et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48, 474–486 (2008).
  PubMed Google Scholar
• Mari, M. et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4, 185–198 (2006).
  CAS PubMed Google Scholar
• Matsuzawa, N. et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46, 1392–1403 (2007).
  CAS PubMed Google Scholar
• Ouyang, X. et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48, 993–999 (2008).
  CAS PubMed PubMed Central Google Scholar
• Abdelmalek, M. F. et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51, 1961–1971 (2010).
  CAS PubMed Google Scholar
• Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M. & Lustig, R. H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7, 251–264 (2010).
  CAS PubMed Google Scholar
• Spruss, A. et al. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50, 1094–1104 (2009).
  CAS PubMed Google Scholar
• Bergheim, I. et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48, 983–992 (2008).
  CAS PubMed Google Scholar
• Tetri, L. H., Basaranoglu, M., Brunt, E. M., Yerian, L. M. & Neuschwander-Tetri, B. A. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G987–G995 (2008).
  CAS PubMed PubMed Central Google Scholar
• Wada, T. et al. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology 151, 2040–2049 (2010).
  CAS PubMed Google Scholar
• Obara, N. et al. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. J. Hepatol. 53, 326–334 (2010).
  CAS PubMed Google Scholar
• Ogawa, T., Fujii, H., Yoshizato, K. & Kawada, N. A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits. Am. J. Pathol. 177, 153–165 (2010).
  CAS PubMed PubMed Central Google Scholar
• London, R. M. & George, J. Pathogenesis of NASH: animal models. Clin. Liver Dis. 11, 55–74 (2007).
  PubMed Google Scholar
• Postic, C. & Girard, J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118, 829–838 (2008).
  CAS PubMed PubMed Central Google Scholar
• Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007).
  CAS PubMed PubMed Central Google Scholar
• Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930–939 (2009).
  CAS PubMed PubMed Central Google Scholar
• Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914–920 (2009).
  CAS PubMed Google Scholar
• Greenberg, A. S. & Obin, M. S. Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 83, 461S–465S (2006).
  CAS PubMed Google Scholar
• Kamada, Y. et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125, 1796–1807 (2003).
  CAS PubMed Google Scholar
• Kamada, Y. et al. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J. Hepatol. 47, 556–564 (2007).
  CAS PubMed Google Scholar
• Asano, T. et al. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. J. Gastroenterol. Hepatol. 24, 1669–1676 (2009).
  CAS PubMed Google Scholar
• Uji, Y. et al. Adiponectin deficiency promotes the production of inflammatory mediators while severely exacerbating hepatic injury in mice with polymicrobial sepsis. J. Surg. Res. 161, 301–311 (2010).
  CAS PubMed Google Scholar
• Ohashi, K. et al. Adiponectin promotes macrophage polarization towards an anti-inflammatory phenotype. J. Biol. Chem. 285, 6153–6160 (2010).
  CAS PubMed Google Scholar
• Tomita, K. et al. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology 48, 458–473 (2008).
  CAS PubMed Google Scholar
• Ouchi, N. et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454–457 (2010).
  CAS PubMed PubMed Central Google Scholar
• Alkhouri, N. et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J. Biol. Chem. 285, 3428–3438 (2010).
  CAS PubMed Google Scholar
• Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197–208 (2010).
  CAS PubMed PubMed Central Google Scholar
• Cai, D. et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183–190 (2005).
  CAS PubMed PubMed Central Google Scholar
• Luedde, T. et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119–132 (2007).
  CAS PubMed Google Scholar
• Wunderlich, F. T. et al. Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proc. Natl Acad. Sci. USA 105, 1297–1302 (2008).
  CAS PubMed PubMed Central Google Scholar
• Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333–336 (2002).
  CAS PubMed Google Scholar
• Shiri-Sverdlov, R. et al. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. J. Hepatol. 44, 732–741 (2006).
  CAS PubMed Google Scholar
• Bieghs, V. et al. Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 138, 2477–2486 (2010).
  CAS PubMed Google Scholar
• Bie, J., Zhao, B., Song, J. & Ghosh, S. Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue. J. Biol. Chem. 285, 13630–13637 (2010).
  CAS PubMed PubMed Central Google Scholar
• Li, T. et al. Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology 52, 678–690 (2010).
  CAS PubMed Google Scholar
• Seki, E. & Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322–335 (2008).
  CAS PubMed Google Scholar
• Miura, K. et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139, 323–334 (2010).
  CAS PubMed Google Scholar
• Velayudham, A. et al. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 49, 989–997 (2009).
  CAS PubMed Google Scholar
• Petersen, K. F. et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc. Natl Acad. Sci. USA 103, 18273–18277 (2006).
  CAS PubMed PubMed Central Google Scholar
• Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).
  CAS PubMed PubMed Central Google Scholar
• He, S. et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 285, 6706–6715 (2010).
  CAS PubMed Google Scholar
• Chen, W., Chang, B., Li, L. & Chan, L. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease. Hepatology 52, 1134–1142 (2010).
  CAS PubMed Google Scholar
• Browning, J. D., Cohen, J. C. & Hobbs, H. H. Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease. Hepatology 52, 1189–1192 (2010).
  CAS PubMed Google Scholar
• Petersen, K. F. et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N. Engl. J. Med. 362, 1082–1089 (2010).
  CAS PubMed PubMed Central Google Scholar
• Salerno, A. G. et al. Overexpression of apolipoprotein CIII increases and CETP reverses diet-induced obesity in transgenic mice. Int. J. Obes. (Lond.) 31, 1586–1595 (2007).
  CAS Google Scholar
• Ito, Y., Azrolan, N., O'Connell, A., Walsh, A. & Breslow, J. L. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249, 790–793 (1990).
  CAS PubMed Google Scholar
• Korenblat, K. M., Fabbrini, E., Mohammed, B. S. & Klein, S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134, 1369–1375 (2008).
  CAS PubMed Google Scholar